Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 373

1.

Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics.

Pantazopoulos H, Stone D, Walsh J, Benes FM.

Synapse. 2004 Dec 1;54(3):147-55.

PMID:
15452863
2.

Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia.

Heckers S, Stone D, Walsh J, Shick J, Koul P, Benes FM.

Arch Gen Psychiatry. 2002 Jun;59(6):521-9.

PMID:
12044194
3.
4.
6.

Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder.

Gaughran F, Payne J, Sedgwick PM, Cotter D, Berry M.

Brain Res Bull. 2006 Jul 31;70(3):221-7. Epub 2006 May 12.

PMID:
16861106
8.

Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.

Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE Jr, Jones EG.

Arch Gen Psychiatry. 1995 Apr;52(4):258-66.

PMID:
7702443
9.

A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives.

Benes FM, Kwok EW, Vincent SL, Todtenkopf MS.

Biol Psychiatry. 1998 Jul 15;44(2):88-97.

PMID:
9646890
11.

Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia.

Eastwood SL, McDonald B, Burnet PW, Beckwith JP, Kerwin RW, Harrison PJ.

Brain Res Mol Brain Res. 1995 Apr;29(2):211-23.

PMID:
7609609
12.

Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study.

Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR, Impagnatiello F, Pandey G, Pesold C, Sharma R, Uzunov D, Costa E.

Arch Gen Psychiatry. 2000 Nov;57(11):1061-9. Erratum in: Arch Gen Psychiatry 2002 Jan;59(1):12. DiGiorgi Gerevini V [corrected to Di-Giorgi-Gerevini V].

PMID:
11074872
13.

Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia.

López-Figueroa AL, Norton CS, López-Figueroa MO, Armellini-Dodel D, Burke S, Akil H, López JF, Watson SJ.

Biol Psychiatry. 2004 Feb 1;55(3):225-33. Erratum in: Biol Psychiatry. 2004 Mar 15;55(6):660.

PMID:
14744462
14.

Alteration in estrogen receptor alpha mRNA levels in frontal cortex and hippocampus of patients with major mental illness.

Perlman WR, Tomaskovic-Crook E, Montague DM, Webster MJ, Rubinow DR, Kleinman JE, Weickert CS.

Biol Psychiatry. 2005 Nov 15;58(10):812-24. Epub 2005 Aug 22.

PMID:
16112656
16.
17.
18.

Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus.

Ohnuma T, Tessler S, Arai H, Faull RL, McKenna PJ, Emson PC.

Brain Res Mol Brain Res. 2000 Dec 28;85(1-2):24-31.

PMID:
11146103
19.

Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects.

Benes FM, Vincent SL, Marie A, Khan Y.

Neuroscience. 1996 Dec;75(4):1021-31.

PMID:
8938738
20.

Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses.

Law AJ, Deakin JF.

Neuroreport. 2001 Sep 17;12(13):2971-4.

PMID:
11588613

Supplemental Content

Support Center